Tevogen Bio Holdings Inc.
TVGN
$0.39
-$0.02-4.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.73M | -5.50M | -10.37M | -9.44M | -5.88M |
| Total Depreciation and Amortization | 27.20K | 290.80K | 105.40K | 103.50K | 101.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 3.18M | 3.24M | 7.30M | 7.04M | 3.13M |
| Change in Net Operating Assets | -1.13M | -1.21M | -349.80K | -749.00K | -1.15M |
| Cash from Operations | -3.65M | -3.19M | -3.31M | -3.05M | -3.80M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 1.40M | 2.00M | 0.00 | 1.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.10M | 500.00K | 2.00M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 2.00M | 4.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00K | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 4.00M | 1.90M | 4.00M | 2.00M | 5.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 351.90K | -1.29M | 691.90K | -1.05M | 1.20M |